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Abstract
Objectives: The prognostic importance of perineural invasion (PNI) in prostate cancer (PC) has been pos-
tulated by some authors. Few studies have investigated the risk factors associated with PNI. The aim of this
study was to identify factors associated with PNI in PC.
Patients and methods: The study group of 113 patients diagnosed with PC during the period 2005–2010
consisted of 66 who underwent radical prostatectomy (RP) and 66 who did not. Each group was further
divided into those with and without PNI. The association between clinicopathological parameters and PNI
in prostate biopsy (Pbx) and RP specimens was investigated using t-test and logistic regression analysis.
Discordance in PNI prevalence and PNI up-migration between Pbx and RP specimens were also studied.
Results: In patients who did not undergo RP, Pbx Gleason score (GS) ≥ 7 was a significant predictor for
the presence of PNI. In patients who underwent RP, Pbx GS > 7 increased the risk of PNI in Pbx and RP
samples, while a high RP GS predicted PNI in the RP specimen. The discordance rate for PNI in Pbx and
RP specimens was 27.3%. Up-migration to a PNI positive cancer between Pbx and RP specimens was seen
in 45.5% of cases and RP GS was the only factor associated with PNI up-migration.∗ Corresponding author. Tel.: +963 955461684.
-mail address: saadat hos@yahoo.com (S.H. Saadat).
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Conclusion: The association of PNI with a high GS and the high rate of discordance between Pbx and RP
specimens indicate that in patients with a high GS on Pbx, the pathologist should look more carefully for
PNI, and the surgeon should be aware of sampling errors and the unreliability of Pbx specimens in detecting
PNI.
© 2012 Production and hosting by Elsevier B.V. on behalf of Pan African Urological Surgeons’ Association.
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Pbx (group 2) (Table 1). The mean patient age was not statistically
different between the two groups. There were statistically significant
differences in mean serum PSA (p = 0.04) and mean biopsy GS
(p = 0.01) between the groups (Table 1). On uni- and multivariate
Table 1 Clinical and pathological characteristics in groups 1 and
2.
Patient characteristics Group 1
N (%)
66 (58.4%)
Group 2
N (%)
47 (41.6%)
Age (years)
50–59 5 (7.6%) 3 (6.4%)
60–69 22 (33.3%) 22 (46.8%)
70–79 27 (40.9%) 16 (34%)
80 and above 12 (18.2%) 6 (12.8%)
Mean age 70.9 ± 8.6 69.5 ± 8.3
Smoking
Smoker 35 (53%) 21 (44.7%)
Non-smoker 31 (47%) 26 (55.3%)
PSA (ng/ml)
<10 5 (7.6%) 3 (6.4%)
10–20 5 (7.6%) 4 (8.5%)
>20 56 (84.8%) 4 (85.1%)
Mean PSA 233.3 ± 454.8 97.1 ± 107.6
Biopsy GS
<7 12 (18.2%) 19 (40.4%)
ND licIntroduction
Prostate cancer (PC) is common, with an estimated 218,890 new
diagnoses and 27,050 deaths in the USA in 2007 [1]. PC is usually
diagnosed by means of transrectal ultrasound-guided biopsy and
the type of treatment chosen is based on prognostic parameters such
as the patient’s age, serum PSA levels, Gleason score (GS), tumor
volume, the presence of perineural invasion (PNI) and tumor stage
[2–5].
PNI is defined as infiltration of cancer cells in the epineurium and
perineurium, or even the endoneurium. The involvement of periph-
eral nerves has been overlooked for a long time but is now receiving
more attention as a potentially important component of the cancer
microenvironment [6]. One reason for the prognostic importance
of PNI is the possibility of metastatic spread of cancer cells along
nerves. Although the effect of PNI on long-term outcome in patients
with PC has been challenged by some authors [7,8], its importance
in making treatment decisions cannot be overlooked [9].
PNI is associated with higher grade and stage in radical prostatec-
tomy (RP) specimens [10] and it may have prognostic value after
RP or external beam radiotherapy (RT) for localized and low risk
PC [2,3]. D’Amico et al. considered PNI an independent prognostic
factor for PC recurrence [2]. Resection of the neurovascular bun-
dle on the side of biopsy detected PNI may decrease the positive
surgical margin rate and improve outcome for low risk patients [2].
Therefore, until it is proven that PNI has no prognostic significance,
the decision to perform nerve-sparing surgery should be made with
care.
Because biopsy samples may not be representative of the real extent
of PNI [2,9], pathologists should carefully examine Pbx and RP
specimens, and urologists should not rely on the results of Pbx
samples alone to determine the presence of PNI.
The objective of this study was to assess the association of patient
age, smoking history, serum PSA and GS with the presence of PNI
in the Pbx and RP samples of patients with PC, and to determine
whether these factors could predict up-migration from a cancer with
no PNI to a PNI positive cancer.
Subjects and methods
A total of 208 patients were diagnosed with PC by means of tran-
srectal ultrasound guided sextant Pbx at two University Hospitals
between 2005 and 2010. The exclusion criteria were [1] patients
Open access under CC BY-NC-diagnosed with PC after a simple prostatectomy or transurethral
resection of the prostate (TURP), [2] patients with transitional
cell carcinoma (TCC) of the bladder invading the prostate, [3] if
the pathology reports of both Pbx and retropubic RP were notvailable and [4] patients diagnosed at other centers whose Pbx
as not reviewed by our hospital’s pathologist.
he study population consisted of 113 patients who were not suitable
andidates for RP and 66 who had undergone RP. The association
etween clinical and pathological data and PNI in Pbx and RP sam-
les was analyzed in each group. Clinical data included the patient’s
ge, smoking history and serum PSA level, while pathological data
ncluded histological grade (Gleason score).
he discordance rate with regard to PNI prevalence between Pbx
nd RP samples was studied, and the PNI up-migration rate between
bx and RP specimens was calculated.
tatistical analysis was performed using the t-test and logistic
egression analysis (univariate and multivariate). A p-value <0.05
as accepted as statistically significant.
esults
here were 113 patients who had undergone Pbx but not RP, 66
howed evidence of PNI (group 1) while 47 had no PNI in the
ense.7 25 (37.9%) 14 (29.8%)
>7 29 (43.9%) 13 (27.7%)
Mean biopsy GS 7.4 ± 1.2 6.7 ± 1.7
Missing data 1 (2.1%)
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Table 2 Univariate analysis of association between GS and PNI.
GS Groups 1 and 2 Groups 3 and 4 Groups 5 and 6
p-Value Crude OR CI p-Value Crude OR CI p-Value Crude OR CI
Pbx GS
All 0.018 1.393 1.06–1.83 0.002 2.38 1.36–4.14 0.003 2.3 1.33–3.96
<7 ref. ref. ref. ref. ref. ref. – – –
7 0.04 2.83 1.02–7.49 0.20 2.27 0.65–7.92 – – –
>7 0.01 3.53 1.33–9.36 0.01 20.40 2.19–190 – – –
RP GS
All – – – – – – 0.021 1.46 1.06–2.00
<7 – – – – – – ref. ref. ref.
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nalysis there were no significant associations between patient age,
moking history or serum PSA and PNI. Univariate analysis showed
significant association between high Pbx GS and PNI (Table 2).
ultivariate analysis confirmed this association (p = 0.034 for all
S, p = 0.03 for Pbx GS = 7, and p = 0.01 for Pbx GS > 7).
omparison of the 66 patients who had undergone RP and the 113
ho had undergone Pbx but not RP showed that the former group had
ignificantly lower mean age (64.8 years vs 70.3 years, p = 0.000),
erum PSA (16.7 ng/ml vs 176.7 ng/ml, p = 0.001) and Pbx GS (6.6
s 7.1, p = 0.000). In the group of 66 patients who had undergone RP,
2 had PNI in the Pbx (group 3) and 44 did not (group 4) (Table 3).
he mean age and PSA were not significantly different between
h
i
(
Table 3 Clinical and pathological characteristics in patients who had un
Group 3N (%)22 (33.3%) Group 4N (%)44 (66.
Age (years)
<50 1 (4.5%) 0 (0%)
50–59 4 (18.2%) 9 (20.5%)
60–69 8 (36.4%) 24 (54.5%)
70–79 9 (40.9%) 10 (22.7%)
≥80 0 (0%) 0 (0%)
Missing data 1 (2.3%)
Mean 65.2 ± 8 64.6 ± 6.7
Smoking
Smoker 10 (45.5%) 21 (47.7%)
Non-smoker 11 (50%) 21 (47.7%)
Missing data 1 (4.5%) 2 (4.5%)
PSA (ng/ml)
<10 3 (13.6%) 18 (40.9%)
10–20 11 (50%) 15 (34.1%)
>20 5 (22.7%) 9 (20.5%)
Missing data 3 (13.6%) 2 (4.5%)
Mean 18.6 ± 12.4 15.9 ± 13.3
Pbx GS
<7 10 (45.5%) 34 (77.3%)
7 6 (27.3%) 9 (20.5%)
>7 6 (27.3%) 1 (2.3%)
Missing data 0 (0%) 0 (0%)
Mean 6.8 ± 1.1 5.6 ± 1.3
RP GS
<7 – –
7 – –
>7 – –
Missing data – –
Mean – –– 0.355 1.73 0.54–5.54
– 0.017 5.769 1.36–24.5
hese two groups, but Pbx GS was significantly different (p = 0.00).
nivariate analysis showed no association of patient age, smoking
istory or PSA with PNI. Univariate analysis showed a significant
ssociation between Pbx GS and PNI (Table 2). Multivariate analysis
id not show a significant association, possibly because of the small
ample size.
n the group that had undergone RP, 40 patients had PNI in the RP
pecimen (group 5) while 26 patients did not (group 6). Univariate
nalysis showed no significant association of patient age, smoking
istory and PSA with PNI, but Pbx GS and RP GS were signif-
cantly associated with the presence of PNI in the RP specimen
Table 2).
dergone RP.
7%) Group 5N (%)40 (60.6%) Group 6N (%)26 (39.4%)
1 (2.5%) 0 (0%)
10 (25%) 3 (11.5%)
16 (40%) 16 (61.5%)
13 (32.5%) 6 (23.1%)
0 (0%) 0 (0%)
0 (0%) 1 (3.8%)
64.0 ± 8.1 66.1 ± 5.1
21 (52.5%) 11 (42.3%)
18 (45%) 13 (50%)
1 (2.5%) 2 (7.7%)
10 (25%) 11 (42.3%)
20 (50%) 6 (23.1%)
7 (17.5%) 7 (26.9%)
3 (7.5%) 2 (7.7%)
15.3 ± 9.7 18.9 ± 16.3
23 (57.5%) 21 (80.8%)
10 (25%) 5 (19.2%)
7 (17.5%) 0 (0%)
0 (0%) 0 (0%)
6.5 ± 1.2 5.4 ± 1.2
13 (32.5%) 15 (57.7)
12 (30%) 8 (30.8)
15 (37.5%) 3 (11.5)
0 (0%) 0 (0%)
6.0 ± 1.7 7.0 ± 1.6
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Table 4 Clinical and pathologic characteristics of groups 7 and 8.
Characteristics Group 7
N (%)
20 (45.5%)
Group 8
N (%)
24 (54.5%)
Age (years)
<50 0 (0%) 0 (0%)
50–59 4 (20%) 5 (20.8%)
60–69 11 (55%) 13 (54.2%)
70–79 5 (25%) 5 (20.8%)
80 and above 0 (0%) 0 (0%)
Missing data 0 (0%) 1 (4.2%)
Mean age 64.8 ± 6.7 64.5 ± 6.8
Smoking
Smoker 11 (55%) 10 (41.7%)
Non-smoker 8 (40%) 13 (54.2%)
Missing data 1 (5%) 1 (4.2%)
PSA (ng/ml)
<10 6 (30%) 12 (50%)
10–20 7 (35%) 8 (33.3%)
>20 6 (30%) 3 (12.5%)
Missing data 1 (5%) 1 (4.2%)
Mean PSA 18.5 ± 14.9 13.7 ± 11.7
Pbx GS
<7 14 (70%) 20 (83.3%)
7 5 (25%) 4 (16.7%)
>7 1 (5%) 0 (0%)
Missing data 0 (0%) 0 (0%)
Mean 6.0 ± 1.4 5.3 ± 1.3
RP GS
<7 11 (55%) 16 (66.7%)
7 4 (20%) 8 (33.3%)
>7 5 (25%) 0 (0%)
Missing data 0 (0%) 0 (0%)
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The 27.3% discordance rate in PNI between Pbx and RP specimensMean 6.5 ± 1.6 5.5 ± 1.5
Out of 66 patients who underwent RP, 40 (60.6%) had PNI in the
RP specimen and 22 (33.3%) had PNI in the Pbx report, i.e. there
was a discordance rate of 27.3% between Pbx and RP pathology
reports. In order to study the factors increasing the risk of PNI up-
migration, the 44 patients who had no PNI before RP (group 4)
were further divided into 20 patients (45.5%) who showed PNI in
the RP specimen (group 7) and 24 patients (54.5%) with no PNI in
the RP specimen (group 8) (Table 4). The only significant difference
between these groups was the mean RP GS (p = 0.04). Univariate
analysis showed a significant association of PNI up-migration with
RP GS (p = 0.05), but not with age, smoking, PSA and Pbx GS.
Multivariate analysis did not show a significant association between
PNI and RP GS, probably due to small patient numbers.
Discussion
It has been recommended to search for PNI in the Pbx sample, in
order to use its prognostic value to select the most suitable therapy,
and in the RP specimen to better determine the biological nature of
the disease and to select adequate integrative therapies [9]. Although
some authors showed that PNI does not predict biochemical recur-
rence [11,12], others have shown that the presence of PNI in the
Pbx specimen represents an independent risk factor for biochemical
recurrence in patients treated by RP or RT [2,3]. It has also been sug-
gested that PNI has a predictive role in patients with a preoperative
PSA > 10 ng/ml [13].
(
t
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lthough some authors have shown that nerve-sparing RP does
ot compromise the outcome in patients with PNI [8], others have
hown that patients who had the corresponding neurovascular bun-
le resected had a significantly lower positive margin rate compared
o those who had the neurovascular bundle spared (11% vs 100%)
2]. Patients with pathological stage T2 tumors and PNI were found
o present a higher than pT2 stage and higher GS [10]. Stone et al.
eported that PNI in RP specimens predicted pelvic lymph node
etastases in men with PC [14]. A decrease in PSA progression-
ree survival after RT for low-risk patients with PNI-positive Pbx
pecimens was also found [3]. Although pathological features of
C are important outcome predictors, and some studies have inves-
igated the association of clinical features with GS [15–18], very
ew studies have addressed PNI.
ur study showed that the patient’s age had no association with PNI
n Pbx or RP specimens. This differs from the findings of Antunes
t al. [18] who showed that the <50 year and >81 year age groups
howed higher percentages of PNI. This difference may be the result
f the small number of patients >80 or <50 years old in our study.
here appear to be no studies that have investigated smoking as a
ariable associated with PNI in PC. Our study showed no association
etween a smoking history and PNI.
lthough several studies have shown an association between serum
SA and GS [15,16], few have investigated its association with
NI. Two studies have shown a statistically significant association
etween the presence of PNI in RP specimens and higher preop-
rative serum PSA [19,20]. Our study showed that in patients who
id not undergo RP there was a significant difference in mean PSA
etween patients with and without PNI in the Pbx specimen, and
nivariate analysis showed a trend toward association with PNI
p = 0.09). This trend was lost in patients who underwent RP, possi-
ly due to the small sample size (PSA > 20 ng/ml was seen in only
patients in group 3 and in 9 patients in group 4). Considering
he significantly lower PSA in RP patients, this supports a possible
ssociation between PSA and PNI.
ur study showed a significant association between GS and PNI in
oth Pbx and RP specimens. This is concordant with the findings of
eard et al. [3] who found a strong association between the presence
f PNI in the Pbx specimen and a Pbx GS of 7–10. Although Loeb
t al. showed that PNI is an independent risk factor for aggressive
athology [8], they did not investigate whether the reverse is also
rue (presence of PNI predicting aggressive pathology). Cambruzzi
t al. showed that GS had a significant association with pathologi-
al criteria such as extra-capsular extension, PNI, lymphovascular
nvasion and staging [21].
n interesting finding in our study was that PNI in the RP sample
as associated with high GS both in Pbx and RP samples, which
s concordant with the findings of Lee et al. [6]. In patients who
nderwent RP, PNI was found in 33.3% of Pbx specimens and 60.6%
f RP specimens. Other researchers have reported the prevalence of
NI in Pbx specimens as 7–43% and in RP specimens as 31.9–79.0%
2,6,8,22].60.6% vs 33.3%) confirms the unreliability of Pbx in determining
he true features of PC. Discordance rates in other studies varied
rom 13% (15.8% vs 2.8%) reported by Nayyar et al. [22] to 45.4%
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52.8% vs 7.4%) reported by Lee et al. [6]. In our study, PNI up-
igration was significantly seen in patients with higher RP GS, but
his association was not seen with Pbx GS.
limitation of our study was that detailed pathology reports (includ-
ng percentage or laterality of cancer, primary and secondary GS and
aterality of PNI) were not available for all patients. Another limi-
ation was the relatively small number of patients, especially those
ho underwent RP.
onclusion
he association of PNI with a high GS and the high rate of discor-
ance between Pbx and RP specimens indicate that in patients with
high GS on Pbx the pathologist should look more carefully for
NI, and the urologist should be aware of sampling errors and the
nreliability of Pbx specimens in detecting PNI.
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